According to Fusion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.93. In 2022 the company made an earnings per share (EPS) of -$2.00 a decrease over its 2021 EPS that were of -$1.90.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.93 | -3.5% |
2022 | -$2.00 | 5.26% |
2021 | -$1.90 | -90.38% |
2020 | -$19.75 | 2498.73% |
2019 | -$0.76 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 12.95% | ๐บ๐ธ USA |